Skip to main navigation
Skip to search
Skip to main content
Aston Research Explorer Home
Help & FAQ
Home
Research units
Profiles
Research Outputs
Datasets
Student theses
Activities
Press/Media
Prizes
Equipment
Search by expertise, name or affiliation
Drugs on the horizon for diabesity
Clifford J. Bailey
*
*
Corresponding author for this work
School of Biosciences
College of Health and Life Sciences
Aston Research Centre for Health in Ageing
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Drugs on the horizon for diabesity'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Incretins
100%
Peroxisome Proliferator-Activated Receptors
92%
Type 2 Diabetes Mellitus
86%
pramlintide
66%
Islet Amyloid Polypeptide
53%
Rimonabant
53%
Insulin
52%
Exenatide
52%
Dipeptidyl Peptidase 4
51%
Cannabinoid Receptors
48%
Pharmaceutical Preparations
47%
Hypoglycemic Agents
36%
Tablets
35%
Meals
34%
Type 1 Diabetes Mellitus
34%
Weight Loss
31%
Obesity
26%
Injections
22%
Enzymes
21%
Therapeutics
12%